158 related articles for article (PubMed ID: 20969960)
1. Mitogen-activated protein kinases in hepatocellular carcinoma development.
Min L; He B; Hui L
Semin Cancer Biol; 2011 Feb; 21(1):10-20. PubMed ID: 20969960
[TBL] [Abstract][Full Text] [Related]
2. Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma.
Ito Y; Sasaki Y; Horimoto M; Wada S; Tanaka Y; Kasahara A; Ueki T; Hirano T; Yamamoto H; Fujimoto J; Okamoto E; Hayashi N; Hori M
Hepatology; 1998 Apr; 27(4):951-8. PubMed ID: 9537433
[TBL] [Abstract][Full Text] [Related]
3. Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development.
Wang J; Tai G
Target Oncol; 2016 Dec; 11(6):723-738. PubMed ID: 27392951
[TBL] [Abstract][Full Text] [Related]
4. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line.
Park HJ; Kim BC; Kim SJ; Choi KS
Hepatology; 2002 Jun; 35(6):1360-71. PubMed ID: 12029621
[TBL] [Abstract][Full Text] [Related]
5. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
6. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells.
Stone AA; Chambers TC
Exp Cell Res; 2000 Jan; 254(1):110-9. PubMed ID: 10623471
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocellular carcinoma.
McKillop IH; Schmidt CM; Cahill PA; Sitzmann JV
Hepatology; 1997 Dec; 26(6):1484-91. PubMed ID: 9397988
[TBL] [Abstract][Full Text] [Related]
8. Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents.
Chaparro M; González Moreno L; Trapero-Marugán M; Medina J; Moreno-Otero R
Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1269-77. PubMed ID: 18808443
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.
Liu L; Cao Y; Chen C; Zhang X; McNabola A; Wilkie D; Wilhelm S; Lynch M; Carter C
Cancer Res; 2006 Dec; 66(24):11851-8. PubMed ID: 17178882
[TBL] [Abstract][Full Text] [Related]
10. The role of MAPKs in adipocyte differentiation and obesity.
Bost F; Aouadi M; Caron L; Binétruy B
Biochimie; 2005 Jan; 87(1):51-6. PubMed ID: 15733737
[TBL] [Abstract][Full Text] [Related]
11. Targeted therapy of hepatocellular cancer.
Wysocki PJ
Expert Opin Investig Drugs; 2010 Feb; 19(2):265-74. PubMed ID: 20074016
[TBL] [Abstract][Full Text] [Related]
12. [The role of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance of hepatocellular carcinoma].
Zhu H; Chen XP; Luo SF; Guan J; Zhang WG; Zhang BX; Mao CP
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):917-20. PubMed ID: 17953842
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
Roberts PJ; Der CJ
Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
[TBL] [Abstract][Full Text] [Related]
14. Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation.
Nickischer D; Laethem C; Trask OJ; Williams RG; Kandasamy R; Johnston PA; Johnston PA
Methods Enzymol; 2006; 414():389-418. PubMed ID: 17110204
[TBL] [Abstract][Full Text] [Related]
15. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylated p38 and JNK MAPK proteins in hepatocellular carcinoma.
Wang SN; Lee KT; Tsai CJ; Chen YJ; Yeh YT
Eur J Clin Invest; 2012 Dec; 42(12):1295-301. PubMed ID: 23033928
[TBL] [Abstract][Full Text] [Related]
17. Roles of mitogen-activated protein kinase pathways during Escherichia coli-induced apoptosis in U937 cells.
Wang JH; Zhou YJ; He P; Chen BY
Apoptosis; 2007 Feb; 12(2):375-85. PubMed ID: 17191113
[TBL] [Abstract][Full Text] [Related]
18. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.
Sopontammarak S; Aliharoob A; Ocampo C; Arcilla RA; Gupta MP; Gupta M
Cell Biochem Biophys; 2005; 43(1):61-76. PubMed ID: 16043884
[TBL] [Abstract][Full Text] [Related]
19. [Expression of mitogen-activated protein kinase and its upstream regulated signal in human hepatocellular carcinoma].
Zhu J; Leng X; Dong N; Liu Y; Li G; Du R
Zhonghua Wai Ke Za Zhi; 2002 Jan; 40(1):1-16. PubMed ID: 11955369
[TBL] [Abstract][Full Text] [Related]
20. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.
Johnson GL; Lapadat R
Science; 2002 Dec; 298(5600):1911-2. PubMed ID: 12471242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]